What is Orexo?
Orexo is a pharmaceutical and digital therapeutics company dedicated to addressing unmet needs in substance use disorders and mental health. The company develops innovative products, which are commercialized either directly in the U.S. or through global partnerships. Established in 1995 and headquartered in Uppsala, Sweden, Orexo's strategic focus on improving patient outcomes through advanced therapies positions it as a key player in a rapidly evolving healthcare landscape. The company's commitment to both improved pharmaceuticals and digital solutions highlights a forward-thinking approach to treatment.
How much funding has Orexo raised?
Orexo has raised a total of $141.7M across 4 funding rounds:
Series B
$22.4M
Stock Offering
$35.7M
Debt
$30M
Debt
$53.6M
Series B (2003): $22.4M with participation from HealthCap Partners, Auriga Partners, Apex Venture Partners, Sofinnova Ventures, and Crédit Lyonnais Private Equity
Stock Issuance/Offering (2005): $35.7M led by Undisclosed
Debt (2013): $30M supported by Danske Bank
Debt (2014): $53.6M featuring Undisclosed
Key Investors in Orexo
HealthCap Partners
HealthCap is a private equity firm specializing in creative growth capital and real estate solutions for the strategic needs of the healthcare industry. HealthCap assists its operating partners by providing growth capital, facilitating buy-outs and recapitalizations, and executing strategic healthcare real estate initiatives. Since 1996, HealthCap has sponsored more than $1.1 billion in healthcare sector investments.
Auriga Partners
Auriga Partners is a venture capital firm that invests in early-stage technology companies. Their focus areas typically include software, internet, and digital health.
Sofinnova Ventures
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
What's next for Orexo?
With the recent major strategic investment, Orexo is poised for significant expansion. The enterprise-level funding suggests a focus on scaling commercialization efforts, potentially broadening its product pipeline, and enhancing its digital therapy platforms. This capital infusion will likely accelerate market penetration and further solidify Orexo's position in the competitive substance use disorder and mental health markets. Future developments may include strategic acquisitions or expanded partnerships to leverage its innovative treatment models.
See full Orexo company page
